Compounds > cytarabine

cytarabine and thromboplastin

cytarabine has been researched along with thromboplastin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barr, CF; Conrad, ME; Hardin, JA; Levin, J; Rickles, FR1
Andoh, K; Kobayashi, N; Kubota, T; Sadakata, H; Tanaka, H1
Catane, R; Fridkin, M; Kaufman, S; Kornberg, A; Peller, S1
Goede, A; Kalk, E; Rose, P1
Amirkhosravi, A; Eifrig, B; Fiedler, W; Francis, JL; Hossfeld, DK; Langer, F; Loges, S; Meyer, T1
Koyama, T; Shinki, H; Tsunaka, M1

Other Studies

6 other study(ies) available for cytarabine and thromboplastin

ArticleYear
Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response.
    The Journal of laboratory and clinical medicine, 1977, Volume: 89, Issue:4

    Topics: Cytarabine; Dactinomycin; DNA; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Thromboplastin

1977
Tissue factor released from leukemic cells.
    Thrombosis and haemostasis, 1991, Jan-23, Volume: 65, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Endotoxins; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Prednisolone; Thromboplastin; Tumor Cells, Cultured

1991
Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines.
    Blood, 1990, Aug-15, Volume: 76, Issue:4

    Topics: Blood Coagulation Factors; Cell Line; Cytarabine; Dactinomycin; Humans; Leukocytes, Mononuclear; Lymphocytes; Macrophages; Monocytes; Thromboplastin; Tuftsin

1990
Acute arterial thrombosis in acute promyelocytic leukaemia.
    Clinical and laboratory haematology, 2003, Volume: 25, Issue:4

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cysteine Endopeptidases; Cytarabine; Daunorubicin; Female; Gangrene; Humans; Intermittent Claudication; Ischemia; Leg; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Popliteal Artery; Remission Induction; Smoking; Thioguanine; Thrombophilia; Thromboplastin; Thrombosis; Toes; Tretinoin

2003
An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:5

    Topics: Antineoplastic Agents; Blood Cells; Blood Coagulation; Cell Death; Cells, Cultured; Cytarabine; Daunorubicin; Granulocyte Precursor Cells; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Thromboplastin

2004
Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
    PloS one, 2017, Volume: 12, Issue:4

    Topics: Antineoplastic Agents; Benzoates; Cell Line, Tumor; Cytarabine; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Idarubicin; Leukemia, Myeloid, Acute; Phosphatidylserines; Tetrahydronaphthalenes; Thrombomodulin; Thromboplastin

2017